Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68d424fa8b237d0277b1698ab75a4e74 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 |
filingDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36915819974ecc3b104661a44a294700 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982ac82d59c35c17aa300b9d36500c0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c1db1657670721a3f60eb109f2cbab9 |
publicationDate |
2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021254180-A1 |
titleOfInvention |
Method for the prognosis of melanoma |
abstract |
The present invention refers to an in vitro or ex vivo method for determining the prognosis and/or staging of a melanoma in a subject comprising the steps of: a) measuring the amount of at least one microRNA selected from the group consisting of: miR-21-5p, miR-146a-5p, miR-155-5p, miR-363-5p and miR-584-5p in an isolated biological sample obtained from the subject and b) determining the value of Breslow thickness by regression analysis. |
priorityDate |
2018-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |